Renaissance Capital logo

ROKA News

Roka Bioscience prices IPO at $12, below the $14-$16 range

Roka Bioscience, which develops highly-automated molecular diagnostic testing systems for the detection of foodborne pathogens, raised $60 million by offering 5 million shares at $12, below the $14-$16 range. At its offer price, Roka now commands a market cap of...read more

11 US IPOs planned for the week of Jul 14

The following IPOs are expected to price this week: CareDx (CDNA), which sells molecular diagnostic tests to monitor heart transplants, plans to raise $50 million by...read more

US IPO Pipeline Update: Eight companies added to next week's IPO calendar

Three small and discounted IPOs priced last week, but nothing set terms ahead of the long holiday weekend....read more

Food safety testing company Roka Bioscience sets terms for $75 million IPO

Roka Bioscience, which develops food safety testing equipment that uses molecular diagnostics, announced terms for its IPO on Monday. The Warren, NJ-based company plans to raise $75 million by offering 5.0 million shares at a price range of $14 to $16. At the...read more